SRx Health Solutions Receives NYSE Warning on Listing Compliance

The latest update is out from SRx Health Solutions ( (SRXH) ).

On February 18, 2026, SRx Health Solutions received a public warning letter from NYSE Regulation stating it had violated Sections 301 and 713 of the NYSE American Company Guide. The breaches stemmed from issuing about 7.5 million common shares between December 31, 2025 and January 23, 2026 upon conversion of Series A preferred shares without proper listing approval or compliant shareholder authorization.

The exchange determined that SRx failed to obtain prior NYSE approval for the additional listed securities and that its written-consent shareholder approval was deficient under NYSE’s internal guidance on large share issuances. While all Series A preferred shares have since been converted or redeemed, the warning underscores the company’s noncompliance with continued listing requirements and signals that further violations could expose SRx to more severe regulatory actions, including potential delisting proceedings.

The most recent analyst rating on (SRXH) stock is a Hold with a $0.13 price target. To see the full list of analyst forecasts on SRx Health Solutions stock, see the SRXH Stock Forecast page.

Spark’s Take on SRXH Stock

According to Spark, TipRanks’ AI Analyst, SRXH is a Neutral.

The score is primarily held down by weak financial performance (large losses, high leverage, and negative recent cash flow) and bearish technicals (below key moving averages with negative MACD). Valuation looks optically low but is less reliable given earnings quality, while recent corporate actions modestly offset risk via capital-structure simplification amid a higher-risk strategic pivot.

To see Spark’s full report on SRXH stock, click here.

More about SRx Health Solutions

SRx Health Solutions, Inc. operates in the healthcare sector and is listed on the NYSE American exchange. The company has recently engaged in equity financing involving Series A Convertible Preferred Stock, which can be converted into common shares, affecting its capital structure and share count on the public market.

SRx’s activities around preferred share issuance and conversion indicate an active use of capital markets instruments to raise funds and manage its balance sheet. These transactions have drawn scrutiny from the exchange, highlighting the compliance-sensitive nature of its financing strategy and its obligations under NYSE American listing rules.

Average Trading Volume: 30,018,150

Technical Sentiment Signal: Strong Sell

Current Market Cap: $40.11M

For an in-depth examination of SRXH stock, go to TipRanks’ Overview page.